Related references
Note: Only part of the references are listed.Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial
Vibeke Strand et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Tocilizumab Inhibits Structural Joint Damage in Rheumatoid Arthritis Patients With Inadequate Responses to Methotrexate Results From the Double-Blind Treatment Phase of a Randomized Placebo-Controlled Trial of Tocilizumab Safety and Prevention of Structural Joint Damage at One Year
Joel M. Kremer et al.
ARTHRITIS AND RHEUMATISM (2011)
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
G. Jones et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Newer Biological Agents in Rheumatoid Arthritis Impact on Health-Related Quality of Life and Productivity
Vibeke Strand et al.
DRUGS (2010)
Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol
Johanna M. Hazes et al.
RHEUMATOLOGY (2010)
Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis
Dewy van Hoogmoed et al.
RHEUMATOLOGY (2010)
Use of spydergrams to present and interpret SF-36 health-related quality of life data across rheumatic diseases
V. Strand et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Golimumab inpatients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
Josef S. Smolen et al.
LANCET (2009)
Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA)
Jane T. Osterhaus et al.
ARTHRITIS RESEARCH & THERAPY (2009)
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2008)
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy
E. Keystone et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis
Elena M. Massarotti
CLINICAL THERAPEUTICS (2008)
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin et al.
JOURNAL OF PAIN (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): Evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
Norihiro Nishimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis
Vinod Chandran et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial
R. Westhovens et al.
RHEUMATOLOGY (2006)
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D
SJ Walters et al.
QUALITY OF LIFE RESEARCH (2005)
Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: The veterans arthritis quality of life study
JA Singh et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Share Paper
